CASI: CASI Pharmaceuticals Inc Company Profile & Statistics

About

CASI Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the acquisition, development and commercialization of proprietary therapeutics for the treatment of cancer and other diseases for the global markets, with a focus on China. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. CASI Pharmaceuticals Inc., formerly known as EntreMed, Inc., is headquartered in Rockville, Maryland.

Info & Links

CEO

Wei-Wu He

Headquarters

1701-1702, China Central Office Tower 1 No. 81 Jianguo Road Chaoyang District
Beijing, F4 100025, CHINA

Auditor

KPMG Huazhen LLP

Share holders

Employees

243

CASI Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization²

44.68M

Enterprise Value

53.61M

Enterprise Value/EBITDA(ttm)

-2.94

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.27

Price to Book(mrq)

3.47

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

53.97%

Operating Margin(ttm)

-133.71%

Profit Margin(ttm)

-162.67%

Return on Equity(ttm)

-181.52%

Return on Invested Capital(ttm)

-92.47%

Return on Assets(ttm)

-45.72%

Income Statement

Revenue(ttm)

16.23M

Revenue Per Share(ttm)

Gross Profit(ttm)

9.06M

EBITDA(ttm)³

-18.24M

Net Income Available to Common(ttm)

-21.13M

Diluted EPS(ttm)

-2.23

Share Statistics

Beta (5Y Monthly)

0.56

52-Week Change

-51.18%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

12.18M

% Held by Insiders

21.24%

% Held by Institutions

22.23%

Balance Sheet

Total Cash(mrq)

12.73M

Total Cash Per Share(mrq)

Total Debt(mrq)

18.46M

Total Debt/Equity(mrq)

138.10%

Current Ratio(mrq)

3.20%

Quick Ratio(mrq)

2.32%

Book Value Per Share(mrq)

Cash Flow

Operating Cash Flow Per Share(ytd)

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CASI

CASI Pharmaceuticals Inc

CASI Pharmaceuticals Inc Profile